Is BioLife Solutions Inc (BLFS) overvalued? · $1.05B cap
BioLife Solutions Inc (BLFS) is a medical instruments & supplies company listed on US.
This page asks whether BioLife Solutions Inc (BLFS) looks expensive on cached numbers — not a short thesis.
No cached income statement for BLFS, so there is no earnings base to call rich or cheap.
BLFS currently screens at market cap $1.05B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next BLFS 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the BLFS stock page for the full model, not this heading.
Not investment advice.